The MDR has applied since 26 May 2021. In the US, the Quality Management System Regulation (QMSR) took effect on
Since 1 October 2023, all 510(k) submissions, unless exempted, must be submitted electronically using eSTAR (FDA). For FDA's fiscal year
Under the MDR, clinical evaluation is "a systematic and planned process" (Article 2(44)), and Annex XIV Part A Section 1(a)
The harmonised standards under the MDR are listed in Commission Implementing Decision (EU) 2021/1182 and its amendments. The most recent
For FDA's fiscal year 2027, which started on 1 October 2026, the standard user fee for an original PMA is
Article 5(2) of the MDR requires a device to meet the general safety and performance requirements (GSPR) in Annex I
IEC 81001-5-1:2021, edition 1.0, was published on 16 December 2021. In December 2025, IEC issued Interpretation Sheet 1 and a
In May 2026, FDA finalised "Content of Human Factors Information in Medical Device Marketing Submissions", replacing the December 2022 draft
Article 51 of the MDR, Regulation (EU) 2017/745, divides devices into classes I, IIa, IIb and III, using the 22
Cookies help us improve your experience on our website. By using our site, you consent to the use of cookies as described in this policy.